Back

Generalizability of the FINEARTS-HF Trial to the US Population across the Spectrum of Kidney Risk

11 May 2024 (10:27 - 10:36)
Organised by: Logo
Congress Presentation Part of: New tools to detect and treat acute heart failure Pharmacotherapy HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Muthiah Vaduganathan

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

6 More presentations in this session

Presentation thumbnail
Health coaching improves outcomes of informal caregivers of adults with chronic heart failure: a randomized controlled trial
Professor B. Riegel (Philadelphia, US)
Abstract Slides Video
Presentation thumbnail
Iatrogenic atrial-septal defect as a primary unloading strategy during acute myocardial infarction: insights from patients data based computational hemodynamic and a swine models
Doctor D. Nachman (Jerusalem, IL)
Abstract Slides Video
Presentation thumbnail
A new urinary sodium-based definition of diuretic efficiency: a light at the end of diuretic resistance tunnel?
Doctor M. Pellegrino (Monza, IT)
Abstract Slides Video
Presentation thumbnail
Machine learning based speech classification of patients with heart failure worsening, a pilot study
Doctor D. Inan (Istanbul, TR)
Abstract Slides Video
Presentation thumbnail
The early use of inotropes, BB, SGLT2-i, ARNI and MRA in acute heart failure: the PENTA-HF observational study
Doctor S. Prosperi (Rome, IT)
Abstract Slides Video

Access the full session

Session thumbnail
New tools to detect and treat acute heart failure
Video

The Event

Event poster

Heart Failure 2024

11 May 2024 10:27 CET
You may be interested in
thumbnail
Congress Presentation
Trade-off of risk and benefit of finerenone across the spectrum of kidney function in patients with heart failure with mildly reduced and preserved ejection fraction in the FINEARTS-HF trial
thumbnail
Congress Presentation
Non-steroidal mineralocorticoid receptor antagonists (nsMRAs) in heart failure with mid-range and preserved ejection fraction: establishing a new standard in heart failure care
thumbnail
Congress Presentation
FINEARTS-HF: new paths to improve outcomes in heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources